This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Effect of semaglutide versus placebo on cardiorenal outcomes by prior cardiovascular disease and baseline body mass index: Pooled post hoc analysis of SUSTAIN 6 and PIONEER 6.
Diabetes, obesity & metabolism, 27(10), 5706-5715
Citation
Zhou, Jingmin; Husain, Mansoor; Li, Yang; Liu, Wenyan; Shen, Zewei; Vilsbøll, Tina; Ge, Junbo. (2025). Effect of semaglutide versus placebo on cardiorenal outcomes by prior cardiovascular disease and baseline body mass index: Pooled post hoc analysis of SUSTAIN 6 and PIONEER 6.. Diabetes, obesity & metabolism, 27(10), 5706-5715. https://doi.org/10.1111/dom.16621